163 related articles for article (PubMed ID: 37293256)
61. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
[TBL] [Abstract][Full Text] [Related]
62. A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas.
McGovern SL; Aldape KD; Munsell MF; Mahajan A; DeMonte F; Woo SY
J Neurosurg; 2010 May; 112(5):925-33. PubMed ID: 19799498
[TBL] [Abstract][Full Text] [Related]
63. Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification.
Simon M; Boström J; Koch P; Schramm J
J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):767-73. PubMed ID: 16306156
[TBL] [Abstract][Full Text] [Related]
64. World Health Organization Grade I Convexity Meningiomas: Study on Outcomes, Complications and Recurrence Rates.
Nanda A; Bir SC; Konar S; Maiti TK; Bollam P
World Neurosurg; 2016 May; 89():620-627.e2. PubMed ID: 26704204
[TBL] [Abstract][Full Text] [Related]
65. World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment.
Champeaux C; Wilson E; Brandner S; Shieff C; Thorne L
Br J Neurosurg; 2015; 29(5):693-8. PubMed ID: 26098606
[TBL] [Abstract][Full Text] [Related]
66. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
[TBL] [Abstract][Full Text] [Related]
67. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
Palma L; Celli P; Franco C; Cervoni L; Cantore G
Neurosurg Focus; 1997 Apr; 2(4):e3. PubMed ID: 15096007
[TBL] [Abstract][Full Text] [Related]
68. High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors.
Bender L; Somme F; Lhermitte B; Ahle G; Boone M; Blonski M; Pouget C; Truc G; Cebula H; Noël G
Chin Clin Oncol; 2021 Jun; 10(3):26. PubMed ID: 33752411
[TBL] [Abstract][Full Text] [Related]
69. Early postoperative radiotherapy improves progression free survival in patients with grade 2 meningioma.
Aboukais R; Baroncini M; Zairi F; Reyns N; Lejeune JP
Acta Neurochir (Wien); 2013 Aug; 155(8):1385-90; discussion 1390. PubMed ID: 23728501
[TBL] [Abstract][Full Text] [Related]
70. Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients.
Detti B; Scoccianti S; Di Cataldo V; Monteleone E; Cipressi S; Bordi L; Pellicanò G; Gadda D; Saieva C; Greto D; Pecchioli G; Buccoliero A; Ceroti M; Ammannati F; Biti G
J Neurooncol; 2013 Dec; 115(3):421-7. PubMed ID: 24045968
[TBL] [Abstract][Full Text] [Related]
71. [Relevance of Simpson's grading system for resections in WHO grade I meningiomas].
Otero A; Tabernero MD; Muñoz MC; Sousa P; Miranda D; Pascual D; Gonçalves JM; Ruiz L
Neurocirugia (Astur); 2017; 28(4):176-182. PubMed ID: 28242156
[TBL] [Abstract][Full Text] [Related]
72. Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas.
Tao X; Dong J; Hou Z; Hao S; Zhang J; Wu Z; Liu B
World Neurosurg; 2018 Mar; 111():e880-e887. PubMed ID: 29325940
[TBL] [Abstract][Full Text] [Related]
73. Stereotactic radiation treatment for recurrent nonbenign meningiomas.
Mattozo CA; De Salles AA; Klement IA; Gorgulho A; McArthur D; Ford JM; Agazaryan N; Kelly DF; Selch MT
J Neurosurg; 2007 May; 106(5):846-54. PubMed ID: 17542529
[TBL] [Abstract][Full Text] [Related]
74. Intensity-modulated radiation therapy (IMRT) for meningioma.
Uy NW; Woo SY; Teh BS; Mai WY; Carpenter LS; Chiu JK; Lu HH; Gildenberg P; Trask T; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1265-70. PubMed ID: 12128128
[TBL] [Abstract][Full Text] [Related]
75. Resected WHO grade I meningioma and predictors of local control.
Nowak-Choi K; Palmer JD; Casey J; Chitale A; Kalchman I; Buss E; Keith SW; Hegarty SE; Curtis M; Solomides C; Shi W; Judy K; Andrews DW; Farrell C; Werner-Wasik M
J Neurooncol; 2021 Mar; 152(1):145-151. PubMed ID: 33420897
[TBL] [Abstract][Full Text] [Related]
76. Patterns of failure after stereotactic radiotherapy of intracranial meningioma.
Askoxylakis V; Zabel-du Bois A; Schlegel W; Debus J; Huber P; Milker-Zabel S
J Neurooncol; 2010 Jul; 98(3):367-72. PubMed ID: 20012910
[TBL] [Abstract][Full Text] [Related]
77. Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases.
Wang XQ; Jiang CC; Zhao L; Gong Y; Hu J; Chen H
J Neurosurg Pediatr; 2012 Nov; 10(5):423-33. PubMed ID: 22938082
[TBL] [Abstract][Full Text] [Related]
78. Efficacy of external fractionated radiation therapy in the treatment of meningiomas: a 20-year experience.
Pourel N; Auque J; Bracard S; Hoffstetter S; Luporsi E; Vignaud JM; Bey P
Radiother Oncol; 2001 Oct; 61(1):65-70. PubMed ID: 11578730
[TBL] [Abstract][Full Text] [Related]
79. Comparative Analysis of the MRI Characteristics of Meningiomas According to the 2016 WHO Pathological Classification.
Yu J; Chen FF; Zhang HW; Zhang H; Luo SP; Huang GD; Lin F; Lei Y; Luo L
Technol Cancer Res Treat; 2020; 19():1533033820983287. PubMed ID: 33356976
[TBL] [Abstract][Full Text] [Related]
80. The role of radiotherapy in the management of high-grade meningiomas.
Hwang KL; Hwang WL; Bussière MR; Shih HA
Chin Clin Oncol; 2017 Jul; 6(Suppl 1):S5. PubMed ID: 28758409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
